Department of Infectious Diseases and Respiratory Medicine Berlin, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Institute of Virology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Infection. 2021 Aug;49(4):703-714. doi: 10.1007/s15010-021-01594-w. Epub 2021 Apr 22.
Adequate patient allocation is pivotal for optimal resource management in strained healthcare systems, and requires detailed knowledge of clinical and virological disease trajectories. The purpose of this work was to identify risk factors associated with need for invasive mechanical ventilation (IMV), to analyse viral kinetics in patients with and without IMV and to provide a comprehensive description of clinical course.
A cohort of 168 hospitalised adult COVID-19 patients enrolled in a prospective observational study at a large European tertiary care centre was analysed.
Forty-four per cent (71/161) of patients required invasive mechanical ventilation (IMV). Shorter duration of symptoms before admission (aOR 1.22 per day less, 95% CI 1.10-1.37, p < 0.01) and history of hypertension (aOR 5.55, 95% CI 2.00-16.82, p < 0.01) were associated with need for IMV. Patients on IMV had higher maximal concentrations, slower decline rates, and longer shedding of SARS-CoV-2 than non-IMV patients (33 days, IQR 26-46.75, vs 18 days, IQR 16-46.75, respectively, p < 0.01). Median duration of hospitalisation was 9 days (IQR 6-15.5) for non-IMV and 49.5 days (IQR 36.8-82.5) for IMV patients.
Our results indicate a short duration of symptoms before admission as a risk factor for severe disease that merits further investigation and different viral load kinetics in severely affected patients. Median duration of hospitalisation of IMV patients was longer than described for acute respiratory distress syndrome unrelated to COVID-19.
在资源紧张的医疗体系中,充分的患者分配对于优化资源管理至关重要,这需要详细了解临床和病毒学疾病轨迹。本研究的目的是确定与需要有创机械通气(IMV)相关的风险因素,分析有创和无创机械通气患者的病毒动力学,并对临床病程进行全面描述。
分析了在一家大型欧洲三级保健中心进行的一项前瞻性观察性研究中纳入的 168 例住院成年 COVID-19 患者的队列。
44%(71/161)的患者需要有创机械通气(IMV)。入院前症状持续时间较短(每减少 1 天的比值比 1.22,95%CI 1.10-1.37,p<0.01)和高血压病史(比值比 5.55,95%CI 2.00-16.82,p<0.01)与需要 IMV 相关。接受 IMV 的患者的 SARS-CoV-2 最大浓度更高、下降速度更慢、排毒时间更长(33 天,IQR 26-46.75,与非 IMV 患者的 18 天,IQR 16-46.75 相比,p<0.01)。非 IMV 患者的住院中位时间为 9 天(IQR 6-15.5),而 IMV 患者为 49.5 天(IQR 36.8-82.5)。
我们的研究结果表明,入院前症状持续时间较短是疾病严重程度的一个危险因素,值得进一步研究。严重感染患者的病毒载量动力学也不同。接受 IMV 的患者的中位住院时间比与 COVID-19 无关的急性呼吸窘迫综合征的描述时间更长。